(Q46006970)

18 December 2017

title

Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab. (English)

1 reference

18 December 2017

author name string

Konrad S Staines

series ordinal

1

1 reference

18 December 2017

Bernard Higgins

series ordinal

2

1 reference

18 December 2017

publication date

17 May 2009

1 reference

18 December 2017

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

18 December 2017

volume

108

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

76-80

1 reference

18 December 2017

Wegener's granulomatosis: A case with primary mucocutaneous lesions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Wegener Granulomatosis: An Analysis of 158 Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

B-cell depletion in Wegener's granulomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

The antineutrophil cytoplasmic antibody-associated vasculitides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Wegener's granulomatosis: the current understanding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Strawberry-Like Gingival Tumor as the First Clinical Sign of Wegener's Granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Oral manifestations of Wegener's granulomatosis: a report of three cases and a literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Lingual necrosis as the presenting sign of Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Strawberry gingiva: a distinctive sign in Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Sublingual gland involvement in systemic Wegener's granulomatosis: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

A case of palatal Wegener's granulomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

More than a mouth ulcer. Oral ulcer due to Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Wegener's granulomatosis presenting as oral lesions: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Value of opinion by oral physician in diagnosing Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

'Strawberry gums'--a case of Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Hyperplastic gingivitis: an oral manifestation of Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Strawberry gums: a clinicopathological manifestation diagnostic of Wegener's granulomatosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Wegener's granulomatosis: report of three cases with oral lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Gingival manifestations of Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Limited Wegener's granulomatosis. Report of a case with oral, renal, and skin involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Oral mucosal presentation of lymphoma: report of case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

7 January 2021

Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

[Atypical headache and facial pain as a result of hypertrophic pachymeningitis in C-ANCA-positive Wegener's granulomatosis]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Wegener's granulomatosis presenting as a temporal headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Wegener's granulomatosis: current trends in diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Wegener's granulomatosis: the current view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Two cases of refractory Wegener's granulomatosis successfully treated with rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

Antineutrophil Cytoplasmic Autoantibodies: Disease Associations, Molecular Biology, and Pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.02.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRIPLEO.2009.02.025

1 reference

18 December 2017

PubMed ID

19451001

1 reference

18 December 2017